Search Results

Angel Torres was running out of options. After multiple rounds of chemotherapy and a fruitless search for a bone marrow donor, the 3-year-old’s odds against acute lymphoblastic leukemia were grim. That changed in June, when Phoenix Children’s providers recommended CAR-T cellular therapy, a breakthrough new treatment that uses a patient’s own T-cells to attack and destroy cancer cells. Only available at a handful of children’s cancer centers nationwide, CAR-T worked for Angel, destroying the leukemia cells and giving him a second chance at life.

Following Phoenix Children’s recent recognition from the Greater Phoenix Chamber as Exceptional Innovator, Phoenix Children’s was honored as Large Businesses of the Year during the Chamber’s 31st Annual IMPACT Awards Luncheon. Innovation, growth, quality improvement, and a goal to educate are among what leaders at Phoenix Children’s recognize as its major success drivers.

They’re grace under fire working long hours, making split-second life-changing decisions, while offering unending comfort and support to patients and families who face enormous healthcare challenges. In fact, when patients and their families recount their experiences at Phoenix Children’s, their nursing team is often the first to receive their admiration and gratitude.

Phoenix Children’s, one of the nation’s largest and fastest-growing pediatric healthcare systems, today announced the retirement of Robert L. Meyer, who has served as the organization’s President and CEO for 22 years. Working closely with the Board of Directors to finalize the leadership transition process, including the selection of his replacement, Meyer will officially retire in the summer of 2025, marking the end of an exceptional leadership tenure that has shaped Phoenix Children’s into a nationally recognized institution for children's healthcare.